Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
Eplerenone in Heart Failure Treatment
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
† Study has passed its completion date and status has not been verified in more than two years.